Login / Signup
Revisiting TLR9 as a target for CLL therapy.
Marcin Kortylewski
Published in:
Blood (2021)
Keyphrases
</>
toll like receptor
inflammatory response
immune response
stem cells
mesenchymal stem cells
cell therapy